
Auro Laboratories (ARL) | Financial Analysis & Statements
TL;DR: Financial Overview - Revenue, Profits & Key Metrics
Latest Quarterly: Jun 2025Income Metrics
Revenue
759.5M
Gross Profit
26.3M
3.47%
Operating Income
10.5M
1.38%
Net Income
11.8M
1.55%
EPS (Diluted)
₹0.56
Balance Sheet Metrics
Total Assets
989.1M
Total Liabilities
220.2M
Shareholders Equity
768.9M
Debt to Equity
0.29
Cash Flow Metrics
Revenue & Profitability Trend
Auro Laboratories Income Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Revenue | 3.1B | 3.4B | 3.4B | 3.3B | 2.1B |
Cost of Goods Sold | 3.0B | 3.3B | 3.2B | 3.2B | 2.0B |
Gross Profit | 130.0M | 133.9M | 120.9M | 121.5M | 72.0M |
Gross Margin % | 4.1% | 3.9% | 3.6% | 3.6% | 3.5% |
Operating Expenses | |||||
Research & Development | - | - | 0 | 3.2K | 15.2K |
Selling, General & Administrative | 33.6M | 34.4M | 30.2M | 23.3M | 19.1M |
Other Operating Expenses | 2.5M | 2.3M | 590.9K | 1.1M | 780.5K |
Total Operating Expenses | 36.1M | 36.7M | 30.7M | 24.4M | 19.9M |
Operating Income | 72.1M | 71.4M | 72.0M | 79.7M | 36.9M |
Operating Margin % | 2.3% | 2.1% | 2.1% | 2.4% | 1.8% |
Non-Operating Items | |||||
Interest Income | 912.5K | 661.4K | 994.7K | 650.3K | 2.1M |
Interest Expense | 20.2M | 26.0M | 24.4M | 33.6M | 19.2M |
Other Non-Operating Income | - | - | - | - | - |
Pre-tax Income | 46.5M | 42.4M | 42.3M | 41.3M | 10.1M |
Income Tax | 11.8M | 11.0M | 10.8M | 12.0M | 2.9M |
Effective Tax Rate % | 25.3% | 26.1% | 25.5% | 28.9% | 28.9% |
Net Income | 34.7M | 31.3M | 31.5M | 29.4M | 7.2M |
Net Margin % | 1.1% | 0.9% | 0.9% | 0.9% | 0.3% |
Key Metrics | |||||
EBITDA | 69.9M | 70.6M | 69.3M | 76.0M | 30.2M |
EPS (Basic) | ₹1.89 | ₹2.09 | ₹2.10 | ₹1.96 | ₹0.48 |
EPS (Diluted) | ₹1.89 | ₹2.09 | ₹2.10 | ₹1.96 | ₹0.48 |
Basic Shares Outstanding | 18382721 | 14984721 | 14984721 | 14984721 | 14984721 |
Diluted Shares Outstanding | 18382721 | 14984721 | 14984721 | 14984721 | 14984721 |
Income Statement Trend
Auro Laboratories Balance Sheet From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Assets | |||||
Current Assets | |||||
Cash & Equivalents | 236.4M | 150.3M | 47.6M | 391.8K | 820.1K |
Short-term Investments | - | - | - | - | - |
Accounts Receivable | 490.0M | 416.8M | 531.1M | 610.3M | 499.4M |
Inventory | 143.7M | 66.1M | 62.1M | 73.7M | 60.6M |
Other Current Assets | - | -1.0K | - | 166.4K | 5.2M |
Total Current Assets | 965.8M | 723.9M | 746.5M | 777.0M | 678.0M |
Non-Current Assets | |||||
Property, Plant & Equipment | 0 | 0 | 3.5M | 0 | 3.9M |
Goodwill | - | - | - | - | - |
Intangible Assets | - | - | - | - | - |
Long-term Investments | - | - | - | - | - |
Other Non-Current Assets | 8.5M | 8.5M | 9.3M | 1.0K | - |
Total Non-Current Assets | 23.3M | 18.1M | 13.6M | 12.3M | 11.8M |
Total Assets | 989.1M | 742.0M | 760.1M | 789.4M | 689.8M |
Liabilities | |||||
Current Liabilities | |||||
Accounts Payable | 41.4M | 70.3M | 67.5M | 154.8M | 47.8M |
Short-term Debt | 121.2M | 236.2M | 264.0M | 235.3M | 262.8M |
Current Portion of Long-term Debt | - | - | - | - | - |
Other Current Liabilities | 5.4M | 7.9M | 10.0M | 10.0M | 7.9M |
Total Current Liabilities | 180.3M | 325.8M | 352.7M | 412.4M | 321.7M |
Non-Current Liabilities | |||||
Long-term Debt | 39.9M | 53.7M | 76.2M | 77.3M | 97.8M |
Deferred Tax Liabilities | - | - | - | - | - |
Other Non-Current Liabilities | 1.0K | - | - | 6.0K | - |
Total Non-Current Liabilities | 39.9M | 53.7M | 76.2M | 77.3M | 97.8M |
Total Liabilities | 220.2M | 379.5M | 428.8M | 489.6M | 419.5M |
Equity | |||||
Common Stock | 183.8M | 149.8M | 149.8M | 149.8M | 149.8M |
Retained Earnings | - | - | - | - | - |
Treasury Stock | - | - | - | - | - |
Other Equity | - | - | - | - | - |
Total Shareholders Equity | 768.9M | 362.6M | 331.2M | 299.7M | 270.3M |
Key Metrics | |||||
Total Debt | 161.0M | 289.9M | 340.2M | 312.6M | 360.7M |
Working Capital | 785.5M | 398.1M | 393.8M | 364.7M | 356.3M |
Balance Sheet Composition
Auro Laboratories Cash Flow Statement From 2021 to 2025
Metric | 2025 | 2024 | 2023 | 2022 | 2021 |
---|---|---|---|---|---|
Operating Activities | |||||
Net Income | 46.5M | 42.4M | 42.3M | 41.3M | 10.1M |
Depreciation & Amortization | - | - | - | - | - |
Stock-Based Compensation | - | - | - | - | - |
Working Capital Changes | 80.2M | 100.9M | 101.1M | -98.6M | -36.1M |
Operating Cash Flow | 151.5M | 171.1M | 170.7M | -19.9M | 822.8K |
Investing Activities | |||||
Capital Expenditures | -8.0M | -7.5M | -605.2K | -927.8K | -594.5K |
Acquisitions | - | - | - | - | - |
Investment Purchases | -236.3M | 0 | -25.0M | -1.5M | 0 |
Investment Sales | 0 | 25.0M | 0 | 0 | 2.3M |
Investing Cash Flow | -244.3M | 17.5M | -25.6M | -2.4M | 1.7M |
Financing Activities | |||||
Share Repurchases | - | - | - | - | - |
Dividends Paid | - | - | - | - | - |
Debt Issuance | 0 | 0 | 0 | 0 | 6.2M |
Debt Repayment | -13.8M | -22.5M | -1.1M | -20.6M | 0 |
Financing Cash Flow | 242.7M | -50.3M | 27.6M | -48.1M | 29.9M |
Free Cash Flow | 104.3M | 154.9M | 71.7M | 86.3M | 1.3M |
Net Change in Cash | 150.0M | 138.3M | 172.7M | -70.4M | 32.5M |
Cash Flow Trend
Auro Laboratories Key Financial Ratios
Valuation Ratios
P/E Ratio (TTM)
208.52
Price to Book
10.49
Price to Sales
2.92
PEG Ratio
3.48
Profitability Ratios
Profit Margin
1.29%
Operating Margin
1.38%
Return on Equity
4.52%
Return on Assets
3.51%
Financial Health
Current Ratio
5.36
Debt to Equity
20.95
Beta
0.09
Per Share Data
EPS (TTM)
₹2.10
Book Value per Share
₹41.76
Revenue per Share
₹160.60
Peer Financial Comparison
Company | Market Cap | P/E Ratio | P/B Ratio | ROE | Profit Margin | Debt/Equity |
---|---|---|---|---|---|---|
arl | 9.3B | 208.52 | 10.49 | 4.52% | 1.29% | 20.95 |
KPR Mill | 364.5B | 44.45 | 7.32 | 16.30% | 12.60% | 9.32 |
Trident | 148.4B | 33.66 | 3.30 | 8.00% | 6.27% | 35.39 |
Sanathan Textiles | 42.7B | 28.01 | 2.34 | 8.87% | 5.09% | 59.97 |
Raymond | 41.4B | 90.93 | 1.05 | 183.56% | 271.84% | 17.81 |
Bombay Dyeing | 36.7B | 7.51 | 1.55 | 20.91% | 31.88% | 0.13 |
Financial data is updated regularly. All figures are in the company's reporting currency.